Quadrature Capital’s Diebold Nixdorf Incorporated DBD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q4
Sell
-13,735
Closed -$34K 1212
2022
Q3
$34K Buy
+13,735
New +$45.8K ﹤0.01% 823
2021
Q1
Sell
-10,307
Closed -$110K 1214
2020
Q4
$110K Buy
+10,307
New +$93.6K 0.01% 775
2020
Q1
Sell
-81,348
Closed -$860K 755
2019
Q4
$860K Sell
81,348
-90,826
-53% -$806K 0.03% 292
2019
Q3
$1.93M Buy
172,174
+143,452
+499% +$1.7M 0.09% 206
2019
Q2
$263K Buy
+28,722
New +$300K 0.02% 380
2017
Q2
Sell
-6,691
Closed -$205K 831
2017
Q1
$205K Buy
+6,691
New +$189K 0.01% 587

Other funds holding DBD

Quadrature Capital's DBD Position: Q4 2022 in Review

Quadrature Capital sold out of Diebold Nixdorf Incorporated (DBD) in Q4 2022, closing a stake of 13,735 shares — an estimated $34K sold.

Quadrature Capital first reported a position in DBD in Q1 2017 and held it in 6 quarters. The position peaked at $1.93M in Q3 2019. 148 funds tracked by Wall St. Rank hold DBD as of Q4 2022.

  • Quadrature Capital reported no remaining Diebold Nixdorf Incorporated position as of Q4 2022 after selling out during the quarter.
  • Quadrature Capital sold 13,735 Diebold Nixdorf Incorporated shares in Q4 2022, an estimated $34K.
  • Quadrature Capital first reported a position in Diebold Nixdorf Incorporated in Q1 2017 and held it in 6 quarters.
  • Quadrature Capital's Diebold Nixdorf Incorporated position peaked at $1.93M in Q3 2019.
  • 148 funds tracked by Wall St. Rank held Diebold Nixdorf Incorporated as of Q4 2022.

Based on Quadrature Capital's 13F filing for Q4 2022, filed 14 Feb 2023.